5 results on '"OVERALL survival"'
Search Results
2. Induction Chemotherapy Prior to Chemoradiation Represents Potential New SOC in Locally Advanced Cervical Cancer.
3. Clinical Updates: PROSTATE CANCER. Darolutamide delays time to progression from mHSPC to mCRPC vs placebo.
4. Clinical Updates: PROSTATE CANCER. Survival may be improving in de novo mHSPC, new data suggest.
5. Pembrolizumab/axitinib sustains efficacy in ccRCC at 5-year follow-up.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.